Get started
Author

Miguel Ángel Barba-Romero

Observed names: Barba-Romero, Miguel A., M. Barba-Romero, M.-Á. Barba-Romero, Miguel A. Barba-Romero, Miguel Angel Barba-Romero
ORCID: 0000-0001-5076-607X
Observed ORCID: 0000-0001-5076-607X
OpenAlex ID: A5108504082
Attainment of LDL-Cholesterol Treatment Goals in Patients With Familial Hypercholesterolemia
2016 · Leopoldo Perez de Isla, Rodrigo Alonso, et al. · Journal of the American College of Cardiology · 252
PDF
Quantitative muscle MRI to follow up late onset Pompe patients: a prospective study
2018 · Sebastian Figueroa-Bonaparte, Jaume Llauger, et al. · Scientific Reports · 66
PDF
Long-term effect of 2 intensive statin regimens on treatment and incidence of cardiovascular events in familial hypercholesterolemia: The SAFEHEART study
2019 · Leopoldo Pérez de Isla, Raquel Arroyo-Olivares, et al. · Journal of clinical lipidology · 33
Fabry disease in Spain: description of Spanish patients and a comparison with other European countries using data from the Fabry Outcome Survey (FOS)
2011 · M.-Á. Barba-Romero, A. Rivera-Gallego, et al. · International Journal of Clinical Practice · 30
PDGF-BB serum levels are decreased in adult onset Pompe patients
2019 · Esther Fernández-Simón, Ana Carrasco-Rozas, et al. · Scientific Reports · 19
Clinical profile of women diagnosed with Fabry disease non receiving enzyme replacement therapy
2019 · Miguel Ángel Barba-Romero, Joaquin Serena, et al. · Medicina Clínica · 15
Current status of the immunogenicity of enzyme replacement therapy in fabry disease
2025 · Jorge F. Gómez-Cerezo, Julián Fernández-Martín, et al. · Orphanet Journal of Rare Diseases · 12
PDF
Study of the effect of anti-rhGAA antibodies at low and intermediate titers in late onset Pompe patients treated with ERT
2019 · Esther Fernández-Simón, Ana Carrasco-Rozas, et al. · Molecular Genetics and Metabolism · 11
In Silico Modeling of Fabry Disease Pathophysiology for the Identification of Early Cellular Damage Biomarker Candidates
2024 · Javier Gervas-Arruga, Miguel Ángel Barba-Romero, et al. · International Journal of Molecular Sciences · 9
PDF
Description of clinical and genetic features of 122 patients included in the Spanish Pompe registry
2023 · Rafael Jenaro Martinez-Marin, David Reyes-Leiva, et al. · Neuromuscular Disorders · 9
Screening for late-onset Pompe disease in Internal Medicine departments in Spain
2023 · Mónica López-Rodríguez, Miguel Angel Torralba-Cabeza, et al. · Orphanet Journal of Rare Diseases · 3
PDF
P379 Spanish Pompe registry: new data based on the 130 patients included
2023 · R Martínez Marín, D. Reyes-Leiva, et al. · Neuromuscular Disorders
POMPE DISEASE
2021 · D. Reyes-Leiva, A. Nascimento, et al. · Neuromuscular Disorders
Clinical profile of women diagnosed with Fabry disease non receiving enzyme replacement therapy
2019 · Miguel Ángel Barba-Romero, Joaquin Serena, et al. · Medicina Clínica (English Edition)
Characterisation of plasma lipoprotein particles in spanish patients with lysosomal acid lipase deficiency (LAL-D)
2017 · Enrique Rodríguez-García, Miriam Gil-Serret, et al. · Atherosclerosis
Dried blood spot screening of lysosomal acid lipase deficiency and confirmatory studies in Spanish suspected patients
2016 · Jorge J. Cebolla, Pilar Irun, et al. · Molecular Genetics and Metabolism
Fabry disease in untreated women with enzyme replacement therapy: Symptomatology and clinical profile
2015 · Miguel A. Barba-Romero, Vicente Climent, et al. · Molecular Genetics and Metabolism
Clinical guidelines for late-onset Pompe disease
2012 · Barba-Romero, Miguel A., Barrot, Emilia, et al. · Hispana
Works count: 19
Citation count: 459
H-index: 9
I10-index: 8
Year
Topic
Type